Fig. 4

Clinical course of the patient after tocilizumab re-administration. NSAIDs non-steroidal anti-inflammatory drugs, PSL prednisolone, mPSL methylpredonisolone, TCZ tocilizumab, TAC tacrolimus, KL-6 Krebs von den Lungen-6, sc subcutaneous